Triple-negative breast cancer (TNBC) is a particularly aggressive form of breast cancer that disproportionately affects Black women. Research suggests that Black women are 40% more likely to die from TNBC than white women, underlining a significant racial disparity that must be addressed urgently. This critical issue calls for legislative action to improve research, treatment, and support for those affected by TNBC.

H.R. 1806, the Triple-Negative Breast Cancer Research and Education Act, aims to close this gap by funding robust research initiatives, enhancing educational outreach, and ensuring comprehensive care for patients. This bill seeks to not only improve outcomes for those diagnosed with TNBC but also to pave the way for health equity.  You can read the bill here : https://www.congress.gov/bill/119th-congress/house-bill/1806/text

It's essential for the New Jersey delegation to actively highlight the disparities in TNBC incidences and outcomes during speeches and committee hearings. By drawing attention to these issues, we can push for robust appropriations necessary for the effective implementation of H.R. 1806 once it is authorized.

House leadership and pertinent committees should prioritize this bill, scheduling hearings and advancing it through the legislative process. We encourage you to contact your House Representative to co-sponsor and publicly champion this important legislation, bringing it into the spotlight where it belongs. 

Please join us in advocating for H.R. 1806 to ensure equitable healthcare for all women affected by TNBC. Sign this petition to signal your support for this vital piece of legislation and demand action from our representatives to make it a priority in the legislative agenda.